- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- August 2024
- 83 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Report
- October 2024
- 197 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 187 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 194 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 194 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 192 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 180 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 195 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- November 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- August 2024
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- November 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- July 2024
- 142 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- July 2024
- 143 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- March 2025
- 163 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- March 2025
- 298 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 193 Pages
Global
From €4724EUR$4,950USD£3,958GBP

The Vagus Nerve Stimulation (VNS) market is a subset of the larger Neurology Devices market. VNS is a type of neuromodulation therapy used to treat a variety of neurological conditions, such as epilepsy, depression, and anxiety. It involves the use of an implanted device that sends electrical signals to the vagus nerve, which is located in the neck. The device is programmed to deliver electrical pulses at regular intervals, which can help reduce symptoms of the condition. VNS is a relatively new technology, and its use is growing as more research is conducted on its efficacy.
The VNS market is highly competitive, with a number of companies offering devices and services. Some of the major players in the market include Medtronic, Cyberonics, NeuroPace, and LivaNova. These companies offer a range of products, from implantable devices to software and services. Additionally, there are a number of smaller companies that specialize in VNS technology, such as NeuroSigma, NeuroMetrix, and Stimwave Technologies. Show Less Read more